Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.
about
MCP-1 Levels are Associated with Cardiac Remodeling but not with Resistant HypertensionCorrelations of MCP-1 -2518A>G polymorphism and serum levels with cerebral infarction risk: a meta-analysis.Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline.Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitisRole of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.Thicker Carotid Intima Media Thickness in Children with Monocyte Chemoattractant Protein-1: A-2138T and A-2464G MutationMyocardial production and release of MCP-1 and SDF-1 following myocardial infarction: differences between mice and man.Evaluation of the Effects of Some Brazilian Medicinal Plants on the Production of TNF- α and CCL2 by THP-1 Cells.The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposityTAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in miceThe +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people.Possible Biomarkers of Chronic Stress Induced Exhaustion - A Longitudinal StudyMonocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetesAcute neuronal injury and blood genomic profiles in a nonhuman primate model for ischemic stroke.Interleukin-1β accelerates the onset of stroke in stroke-prone spontaneously hypertensive rats.Pivotal roles of monocytes/macrophages in strokeVascular endothelial growth factor and monocyte chemoattractant protein-1 levels unaltered in symptomatic atherosclerotic carotid plaque patients from north IndiaThe effects of dipeptidyl peptidase-4 inhibitors on cardiovascular disease risks in type 2 diabetes mellitus.Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis, and diabetesChemokines and neurodegeneration in the early stage of experimental ischemic stroke.Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusionChemokines as therapeutic targets for atherosclerotic plaque destabilization and rupture.Role of monocyte chemoattractant protein-1 in myocardial infarction.Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery.Monocytes and monocyte chemoattractant protein 1 (MCP-1) as early predictors of disease outcome in patients with cerebral ischemic stroke.Association of monocyte chemoattractant protein-1 -2518A>G polymorphism with occurrence, severity, and outcome in ischemic stroke.Systemic and Local Cytokine Profile following Spinal Cord Injury in Rats: A Multiplex Analysis.Effect of Rubus Occidentalis Extract on Metabolic Parameters in Subjects with Prediabetes: A Proof-of-concept, Randomized, Double-blind, Placebo-controlled Clinical Trial.
P2860
Q33647436-F6735C19-4562-477D-B06C-540DFDC4C0F4Q33980736-492E7DE5-B324-4D1A-AD9E-BE100067B878Q34027245-76A6DE5A-F68D-4DEB-928E-703955749C85Q34069262-A811D083-2722-4B48-AED0-F0EF1CA2423BQ34170906-87A76226-0D7C-44D7-9363-C3AB889EA0F1Q35173853-144FEBE1-DAD1-4B37-A942-9E925B3369F1Q35233087-0BD9E39B-98B1-4A34-8062-2A388A825B93Q35279021-2F6A9EE6-C94A-40D6-BAA8-36545102B73DQ35504486-CB1DBE54-B3BF-4F14-8482-090E4B2D055CQ35572877-1B72EBA2-1497-44AB-8F8F-137276F4B3B9Q35951580-301E62EC-E668-4538-B52A-8D2A05D39780Q36008329-E5C91894-2176-4B7C-A1C1-817D1309114CQ36222092-A0F83260-5D37-41E5-9A6A-2FF897C85433Q36321402-9A715B44-F44B-4161-A74E-E0CFA8CC8464Q36522750-8DBFFD6A-53DB-436B-B733-8F82B5A2A3B7Q36599944-B5B33083-68E3-457F-87FB-7642D5648EA6Q36733219-5F1B1522-6112-49FB-8240-87699943BC78Q36845055-9603D340-F1F0-4BD6-BB8E-67A9BB2B2A2EQ36943742-B8E5E3A4-EAF0-4D41-AEB2-ED3DD4E02BB5Q37351594-D8F683D9-DE7E-4213-9FC1-F1861DB7D7BEQ37357137-6528137B-F6FF-4655-B967-4C246E05D583Q37486616-3DFABD7F-9A5E-4E8A-8D03-84C24475063DQ38106962-62AAA960-FCAC-4D64-A908-039A4400BF0FQ38114832-EE71C5D5-B35D-4EF4-AE64-CE50CB4B6D3EQ38808589-0B600B1E-2C6D-4391-BEFB-CE9EEC98F1E2Q40350912-7453609C-C333-4F67-938B-4DC0CE11793FQ44667452-8B4C4BF3-304B-4BBB-907A-E9D95DCDCA1EQ45275684-096255C8-7F4F-4A0F-8999-2E9496A2DAEBQ51712403-29CA485D-19F9-4D01-AAB8-935A9A2431DE
P2860
Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Serum levels of the MCP-1 chem ...... oke and myocardial infarction.
@ast
Serum levels of the MCP-1 chem ...... oke and myocardial infarction.
@en
Serum levels of the MCP-1 chem ...... oke and myocardial infarction.
@nl
type
label
Serum levels of the MCP-1 chem ...... oke and myocardial infarction.
@ast
Serum levels of the MCP-1 chem ...... oke and myocardial infarction.
@en
Serum levels of the MCP-1 chem ...... oke and myocardial infarction.
@nl
prefLabel
Serum levels of the MCP-1 chem ...... oke and myocardial infarction.
@ast
Serum levels of the MCP-1 chem ...... oke and myocardial infarction.
@en
Serum levels of the MCP-1 chem ...... oke and myocardial infarction.
@nl
P2093
P2860
P356
P1476
Serum levels of the MCP-1 chem ...... roke and myocardial infarction
@en
P2093
P2860
P304
P356
10.1155/MI.2005.175
P577
2005-08-01T00:00:00Z